Bixiye
QP39-20 Commercial Pharmacy Benefit Exclusion for Beovu®, Quzyttir™, Reblozyl®, Recarbrio™ and Vyepti™
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 08, 2020
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 2541 - 2550 ee natiijooyinka 3289
Bixiye
P21-20 Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2020
Bixiye
P23-20 New Medical, Medical Drug and Behavioral Health Policy Management Updates – Effective June 1, 2020
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2020
Bixiye
P22-20 eviCore to Become Final Reviewer on Appeals for Commercial Members
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2020
Bixiye
P24-20 Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial and Medicare Advantage Subscribers - eviCore Healthcare Specialty Utilization Management (UM) Program
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2020
Bixiye
2020 April Bulletins
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2020
Bixiye
QP32-20 Delay of Inpatient and Outpatient Elective Surgery and Procedure Cases During COVID-19 Peacetime Emergency
Taariikhda uu dhaqangalayo Barnaamijka: Mar 25, 2020
Bixiye
QP35-20 Post Service COVID-19/Coronavirus Claim Appeals
Taariikhda uu dhaqangalayo Barnaamijka: Mar 25, 2020
Bixiye
QP34-20 New Claims Status Online Messaging Available on Availity
Taariikhda uu dhaqangalayo Barnaamijka: Mar 25, 2020
Bixiye
QP33-20 Updates to Telemedicine/Telehealth and Telephone Call Reimbursement Policies
Taariikhda uu dhaqangalayo Barnaamijka: Mar 25, 2020